Where it is registered
Each register with its number of medicines and a few of them.
Brazil
Anvisa · 1 medicine
Spain
AEMPS · 1 medicine · Historical list
Netherlands
CBG-MEB · 1 medicine
New Zealand
PHARMAC · 1 medicine
United States
FDA · 1 medicine
All medicines with Lumefantrine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
5 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| CoartemCombination | United States | 20MG; 120MG | tablet | Marketed | Novartis |
| Riamet 20 mg/120 mg, tablettenCombination | Netherlands | Tablet | Authorised | Novartis Pharma B.V. | |
| CoartemCombination | Brazil | Authorised | Novartis Biociencias S.A | ||
| AnyCombination | New Zealand | Tab 20 mg with lumefantrine 120 mg | Funded | ||
| RIAMET 20 mg/120 mg COMPRIMIDOSCombination | Spain | 20 mg + 120 mg | comprimido | Withdrawn | Novartis Farmaceutica S.A. |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Often combined with
Substances it shares a medicine with.
Names in the registers
How the registers write it, in their own languages.
- Lumefantrina
Sources
Compiled by Prognia from the public medicine registers of AEMPS, Anvisa, CBG-MEB, FDA and PHARMAC. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 5
- Medicines
- 5
- Companies
- 4